About this trial
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Able to understand and comply with study procedures and voluntarily sign a written informed consent document
Age 18 years or older at the time of enrollment
Disqualifiers
Not able to obtain consent
Not able to meet protocol visit requirements
Pregnant at the time of enrollment
Trial population
Patients with SLE
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Identify genetic drivers and antigenic targets, to elucidate mechanistic heterogeneity and correlate biomarkers to therapeutic responses.
Resource intended to be used to address research questions based upon three categorical time frames (historical, cross-sectional, and longitudinal) with specified scientific topics proposed upon request to access the resources.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.